GSID - ETF AI Analysis

Top Page

Goldman Sachs MarketBeta International Equity ETF (GSID)

Rating:66Neutral

Price Target:―

GSID, the Goldman Sachs MarketBeta International Equity ETF, has a solid overall rating driven mainly by high-quality global leaders like Novartis, HSBC, AstraZeneca, Toyota, and ASML, which all show strong financial performance, positive earnings sentiment, and generally supportive valuations or technical trends. These strengths are slightly offset by holdings such as SAP and Shell, where weaker technical momentum, potential overvaluation, or growth challenges introduce some risk. The fund is also notably exposed to large pharmaceutical and healthcare names, which can concentrate its performance in that sector’s fortunes.

Positive Factors

Broad International Diversification

The fund spreads its investments across many countries, including Japan, the UK, and several European and Asia-Pacific markets, which helps reduce reliance on any single economy.

Balanced Sector Mix

Holdings are spread across financials, industrials, health care, technology, and other sectors, helping to cushion the impact if one industry runs into trouble.

Competitive Expense Ratio

The fund’s relatively low expense ratio means less of your return is lost to fees compared with many actively managed international funds.

Negative Factors

Heavy Financials Exposure

A large allocation to financial companies makes the fund more sensitive to banking and interest-rate risks.

Concentration in a Few Countries

Significant weight in markets like Japan and the UK means the fund’s performance can be heavily influenced by economic or political developments in those countries.

Mixed Performance Among Top Holdings

While some leading positions have shown strong gains, others have been weak or lagging, which can create uneven contributions to overall returns.

GSID vs. SPDR S&P 500 ETF (SPY)

AUM955.67M

RegionDeveloped Markets

Expense Ratio0.20%

Beta0.72

IssuerGoldman Sachs

Inception DateMay 12, 2020

Dividend Yield2.43%

Asset ClassEquity

Index TrackedSolactive GBS Developed Markets ex North America Large & Mid Cap Index

Share Statistics

EPS (TTM)N/A

Shares OutstandingN/A

10 Day Avg. Volume2,116

30 Day Avg. Volume23,832

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

P/FCF RatioN/A

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

81.31

Price Target Upside― Downside

Rating ConsensusModerate Buy

Number of Analyst Covering891

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

GSID Summary

The Goldman Sachs MarketBeta International Equity ETF (GSID) is an exchange-traded fund that tracks the Solactive GBS Developed Markets ex North America Large & Mid Cap Index. It invests in many large and mid-sized companies outside the U.S., with big exposure to countries like Japan, the UK, and France. Well-known holdings include Toyota Motor, Nestlé, and AstraZeneca. Someone might invest in GSID to diversify beyond the U.S. and gain broad international stock market exposure in a single fund. A key risk is that international stock prices can go up and down significantly with global market and currency moves.

How much will it cost me?The Goldman Sachs MarketBeta International Equity ETF (GSID) has an expense ratio of 0.20%, which means you’ll pay $2 per year for every $1,000 invested. This is lower than average for ETFs because it is passively managed, tracking an index rather than relying on active management strategies.

What would affect this ETF?Positive drivers for GSID could include strong growth in developed markets outside North America, particularly in sectors like financials and industrials, which make up a significant portion of the ETF's holdings. However, negative factors such as rising interest rates or economic slowdowns in these regions could impact corporate earnings and investor sentiment, especially for top holdings like ASML and Nestlé. Additionally, regulatory changes in key countries or global trade tensions could create uncertainty for the ETF's performance.

GSID Top 10 Holdings

GSID leans heavily on Europe and Japan, with a clear tilt toward financials and industrials rather than U.S.-style Big Tech. ASML is the star of the show, rising strongly and giving the fund a powerful semiconductor engine. Health care giants like Roche and Novartis are also pulling their weight, keeping returns steady. On the flip side, Nestlé and SAP have been lagging, acting like a small anchor on performance. Toyota and Siemens add a steady industrial backbone, helping balance out the weaker consumer and software names.

Name	Company Name	Weight %	Market Value	Market Cap	Yearly Gain	Overall Rating
ASML	ASML Holding NV	2.48%	$23.79M	€475.49B	74.46%	76 Outperform
ROG	Roche Holding AG	1.47%	$14.08M	CHF294.84B	46.01%	73 Outperform
NOVN	Novartis AG	1.37%	$13.09M	CHF242.43B	28.84%	80 Outperform
AZN	AstraZeneca	1.36%	$13.04M	$323.92B	30.42%	80 Outperform
HSBA	HSBC Holdings	1.32%	$12.68M	£222.90B	45.63%	80 Outperform
NESN	Nestlé SA	1.18%	$11.34M	CHF198.29B	10.92%	71 Outperform
7203	Toyota Motor	1.09%	$10.44M	¥48.61T	34.33%	80 Outperform
SHEL	Shell (UK)	1.00%	$9.59M	£165.51B	11.49%	73 Outperform
8306	Mitsubishi UFJ Financial Group	0.95%	$9.10M	¥33.00T	48.01%	76 Outperform
SIE	Siemens	0.94%	$9.03M	€191.01B	9.25%	74 Outperform

GSID Technical Analysis

Technical Analysis Sentiment

Positive

Last Price―

Price Trends

50DMA

71.65

Positive

100DMA

69.29

Positive

200DMA

66.26

Positive

Market Momentum

MACD

1.19

Negative

RSI

68.19

Neutral

STOCH

82.59

Negative

Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For GSID, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 74.19, equal to the 50-day MA of 71.65, and equal to the 200-day MA of 66.26, indicating a bullish trend. The MACD of 1.19 indicates Negative momentum. The RSI at 68.19 is Neutral, neither overbought nor oversold. The STOCH value of 82.59 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for GSID.

GSID Peer Comparison

Comparison Results

Name	Price	Price Target	AUM	Expense Ratio	Overall Rating
GSID	―	―	$955.67M	0.20%	―
IQDG	―	―	$751.62M	0.42%	―
DMXF	―	―	$697.97M	0.12%	―
DWM	―	―	$686.84M	0.48%	―
NUDM	―	―	$679.25M	0.28%	―
EFAX	―	―	$508.75M	0.20%	―

Performance Comparison

GSID

Goldman Sachs MarketBeta International Equity ETF

75.82

19.07

33.60%

IQDG

WisdomTree International Quality Dividend Growth Fund

―

DMXF

iShares ESG Advanced MSCI EAFE ETF

―

DWM

WisdomTree International Equity Fund

―

NUDM

Nuveen ESG International Developed Markets Equity ETF

―

EFAX

SPDR MSCI EAFE Fossil Fuel Free ETF

―

Glossary

BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―

Table of Contents